In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Association of left atrial enlargement with heart failure and cardiovascular events after acute coronary syndromes

Session Poster Session 3

Speaker Paulo Maia Araujo

Congress : Heart Failure 2019

  • Topic : heart failure
  • Sub-topic : Acute Heart Failure - Epidemiology, Prognosis, Outcome
  • Session type : Poster Session
  • FP Number : P1774

Authors : PM Araujo (Porto,PT), S Torres (Porto,PT), C Resende (Porto,PT), A Nunes (Porto,PT), C Sousa (Porto,PT), M Campelo (Porto,PT), F Macedo (Porto,PT), MJ Maciel (Porto,PT)

PM Araujo1 , S Torres1 , C Resende1 , A Nunes1 , C Sousa1 , M Campelo1 , F Macedo1 , MJ Maciel1 , 1Sao Joao Hospital, Cardiology - Porto - Portugal ,


Introduction:  Acute coronary syndromes (ACS) are associated with significant morbidity and mortality not only during the acute phase, but also after the event. The occurrence of new major adverse cardiac and cerebrovascular events (MACCE) and heart failure (HF) during follow-up is difficult to predict.

Purpose:  Evaluate if the presence of left atrial (LA) enlargement (LAE) in the acute phase of ACS was associated with MACCE and/or HF during follow-up.

Methods: Retrospective evaluation of 92 consecutive pts admitted to our center due to ACS, with a follow up of 2 years. Echocardiographic parameters of diastolic function (performed during the first 48h after admission) and clinical data were evaluated. LAE was defined as a body surface area indexed LA volume (ILAV) > 34 ml/m2.  MACCE was defined as the composite of death, ACS, stroke, repeat revascularization (RR) and congestive heart failure requiring hospitalization (CHF) after hospital discharge.

Results: Mean age was 64.6±12.3 years, with a male predominance (73.9%). At the end of follow-up, 44.9% of pts were at NYHA class = 2. These pts had significantly higher ILAV (35.60 vs 29.46 ml/m2; p=0.040) and on univariate analysis, LAE was the only significant predictor of this outcome (OR 4.22; 95% CI 1.67-10.66; p=0.002), while other classic echocardiographic parameters of diastolic function were not (peak E, A and e’ wave velocities; E/A and E/e’ ratios). During follow-up, MACCE occurred in 18 pts (19.6%): death in 6 (6.5%), ACS in 7 (7.6%), RR in 5 (5.4%) and CHF in 4 (4.3%). LAE was associated with significantly higher risk for MACCE (29.3% vs 6.7%; p=0.006; OR 5.79) and on univariate analysis it was a significant predictor of these events (OR 5.79.; 95% CI 1.50-22.36; p=0.011), with an area under the ROC curve of 0.70 (95% CI 0.56-0.84; p=0.018).

Conclusions:  The detection of LAE during the acute phase of ACS was a significant predictor of MACCE and HF during the follow-up, while other parameters of diastolic function weren’t capable to do so.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are